Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.37%
Change (1 year)
Categories
Earnings for Sage Therapeutics (SAGE)
Earnings in 2023 (TTM): -$0.55 B
According to Sage Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.51 B. In 2022 the company made an earning of -$0.54 B a decrease over its 2021 earnings that were of -$0.46 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Sage Therapeutics from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.55 B | 1.61% |
| 2022 | -$0.54 B | 16.36% |
| 2021 | -$0.46 B | -175.55% |
| 2020 | $0.60 B | -189.1% |
| 2019 | -$0.69 B | 82.43% |
| 2018 | -$0.38 B | 38.04% |
| 2017 | -$0.28 B | 69.9% |
| 2016 | -$0.16 B | 68.25% |
| 2015 | -$94.5 M | 179.48% |
| 2014 | -$33.82 M | 84.98% |
| 2013 | -$18.28 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | -$29.44 M | -94.15% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | -$58.01 M | -88.47% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $0.51 B | -201.88% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | $35.65 M | -107.09% | 🇺🇸 USA |